UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Allergan, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
018490102
(CUSIP Number)
December 31, 2013
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
CUSIP: 018490102 Page 1 of 6
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Capital Research Global Investors **
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS) (a)
(b)
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5 SOLE VOTING POWER
17,472,533
6 SHARED VOTING POWER
NUMBER OF
SHARES NONE
BENEFICIALL
Y OWNED BY
7 SOLE DISPOSITIVE POWER
EACH
REPORTING 17,472,533
PERSON
WITH:
8 SHARED DISPOSITIVE POWER
NONE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
17,472,533 Beneficial ownership disclaimed pursuant to Rule
13d-4
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.9%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IA
** A division of Capital Research and Management Company (CRMC)
CUSIP: 018490102 Page 2 of 6
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Amendment No.
Item 1(a) Name of Issuer:
Allergan, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
2525 Dupont Drive
Irvine, CA 92612
Item 2(a) Name of Person(s) Filing:
Capital Research Global Investors
Item 2(b) Address of Principal Business Office or, if none,
Residence:
333 South Hope Street
Los Angeles, CA 90071
Item 2(c) Citizenship: N/A
Item 2(d) Title of Class of Securities:
Common Stock
Item 2(e) CUSIP Number:
018490102
Item 3 If this statement is filed pursuant to sections 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:
(e) [X] An investment adviser in accordance with
section 240.13d-1(b)(1)(ii)(E).
Item 4 Ownership
Provide the following information regarding the aggregate
number and percentage of the class of securities of the issuer
identified in Item 1.
(a) Amount beneficially owned:
(b) Percent of class:
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
(ii) Shared power to vote or to direct the vote:
(iii) Sole power to dispose or to direct the disposition of:
(iv) Shared power to dispose or to direct the disposition of:
See page 2
Capital Research Global Investors is deemed to be the
beneficial owner of 17,472,533 shares or 5.9% of the
297,162,419 shares believed to be outstanding as a result of
CRMC acting as investment adviser to various investment
companies registered under Section 8 of the Investment Company
Act of 1940.
CUSIP: 018490102 Page 3 of 6
Item 5 Ownership of Five Percent or Less of a Class. If this
statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities,
check the following: [ ]
Item 6 Ownership of More than Five Percent on Behalf of Another
Person: N/A
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company or Control Person: N/A
Item 8 Identification and Classification of Members of the Group:
N/A
Item 9 Notice of Dissolution of Group: N/A
Item 10 Certification
By signing below, I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and
are held in the ordinary course of business and were not
acquired and are not held for the purpose of or with the effect
of changing or influencing the control of the issuer of the
securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose
or effect.
Signature
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
Date: February 5, 2014
Signature: Timothy D. Armour***
Name/Title: Timothy D. Armour - Senior Vice President
Capital Research Global Investors
***By /s/ Herbert Y. Poon
Herbert Y. Poon
Attorney-in-fact
Signed pursuant to a Power of Attorney dated January 28, 2014
included as an Exhibit to this Schedule 13G.
CUSIP: 018490102 Page 4 of 6
POWER OF ATTORNEY
The undersigned do hereby appoint Herbert Y. Poon, acting singly,
with full power of substitution, as the true and lawful attorney of the
undersigned, to sign on behalf of the undersigned in respect of the
ownership of equity securities deemed held by the undersigned, Capital
Research Global Investors, AMCAP Fund, American Funds Global Balanced
Fund, American Mutual Fund, American Funds Insurance Series (Blue Chip
Income and Growth Fund, Growth-Income Fund, Global Small Capitalization
Fund, International Fund, International Growth and Income Fund),
Capital Income Builder, Capital International - U.S. Equity Fund,
Capital International European Growth and Income, Capital International
U.S. Growth and Income, Capital World Growth and Income Fund,
EuroPacific Growth Fund, New Perspective Fund, New World Fund, Inc.,
SMALLCAP World Fund, Inc., The Growth Fund of America, The Investment
Company of America, and The New Economy Fund, and to be reported
pursuant to Sections 13(d), 13(f) and 13(g) of the Securities Exchange
Act of 1934, as amended, and to execute joint filing agreements with
respect to such filings.
IN WITNESS WHEREOF, this Power of Attorney has been executed as of
th
the 28 day of January, 2014.
Capital Research Global SMALLCAP World Fund, Inc.
Investors
The Growth Fund of America
/s/ Timothy D. Armour
Name: Timothy D. Armour /s/ Patrick F. Quan
Title: Senior Vice Name: Patrick F. Quan
President
Title: Secretary
AMCAP Fund
American Funds Global American Funds Insurance Series
Balanced Fund
American Mutual Fund
Capital Income Builder
Capital World Growth and /s/ Steven I. Koszalka
Income Fund
EuroPacific Growth Fund Name: Steven I. Koszalka
New Perspective Fund Title: Secretary
New World Fund, Inc.
The Investment Company of
America
The New Economy Fund Capital International - U.S. Equity
Fund
Capital International European
Growth and Income
Capital International U.S. Growth
and Income
/s/ Michael W. Stockton
CUSIP: 018490102 Page 5 of 6
Name: Michael W.
Stockton
Title: Secretary /s/ Todd Wagner
Name: Todd Wagner
Title: CFO and Secretary of the
Trustee
CUSIP: 018490102 Page 6 of 6